USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Asthma/COPD Market
U.S. Asthma/COPD Market
RELEASE DATE
15-Apr-2011
15-Apr-2011
REGION
North America
North America
Research Code: N85C-01-00-00-00
SKU: HC02171-NA-MR_07790
$4,950.00
In stock
SKU
HC02171-NA-MR_07790
Description
This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.
Table of Contents
U.S. Asthma/COPD Market
- Introduction
Research Scope and Methodology
- Scope and Segmentation
- Research Methodology
Market Overview
- Asthma Disease Overview
- COPD Disease Overview
- Market Engineering Measurements
- Patient Forecasts - Asthma
- Patient Forecasts - COPD
- Total Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
Bronchodilators Product Analysis
- Short-Acting Bronchodilators Product Analysis
- Long-Acting Bronchodilators Product Analysis
- Anticholinergics Product Analysis
- Combination Bronchodilators Product Analysis
Anti-Inflammatories Product Analysis
- Inhaled Corticosteroids Product Analysis
- Anti-Leukotriene Product Analysis
- Monoclonal Antibodies Product Analysis
Combination Therapies Product Analysis
- Combination Therapies Product Analysis
Pipeline Analysis
- Phase III Pipeline Analysis
Total Market Forecasts
Revenue Forecasts for Bronchodilators
Revenue Forecasts for Anti-Inflammatories
Revenue Forecasts for Combination Therapies
Competitive Analysis
Market Share Analysis
- Revenue Forecasts for Total Asthma/COPD Market
Decision Support Databases
Popular Topics
This research service provides an in depth analysis of factors affecting the growth of the U.S. asthma/COPD market over the period 2006-2016. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts, and market share analysis. The market is segmented by mechanisms of action: anti-inflammatories, bronchodilators, and combination therapies. Major market challenges, drivers, and restraints and identified and discussed. Included are examinations of therapeutic candidates in the asthma/COPD pipeline for phase III.
| No Index | No |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | N85C-01-00-00-00 |
| Is Prebook | No |